Top Story

New collaboration looks to bring potential liver cancer, melanoma drug to China

July 2, 2015

Provectus Biopharmaceuticals, Inc. announced it has signed a Letter of Intent with Boehringer Ingelheim Investment Co. Ltd. in China to collaborate in marketing its potential liver cancer and melanoma drug, PV-10, in mainland China, Hong Kong and Taiwan, according to a press release.

Under the agreement, Boehringer will provide commercial support in regards to product registration with the China FDA, communication preparation, market intelligence and other assistance to Provectus in China to the extent that is within Boehringer’s approved business scope and permissible by Chinese laws, according to the release.

Ran Reshef, MD In the Journals

Higher CD8 T-cell dose from younger donors improves allogeneic HSCT outcomes

July 2, 2015
A higher graft CD8 dose from younger donors — even if they are not related to the patient — predicted improved survival in patients with hematologic…
In the Journals

Clonal hematopoiesis common, variable in patients with aplastic anemia

July 2, 2015
Clonal hematopoiesis commonly occurs in patients with aplastic anemia, according to study results. Although detected somatic mutations were associated with clinical…
Petros Grivas, MD, PhD Meeting News Coverage

Top Takeaways from ASCO: Urothelial Cancer

July 1, 2015
CHICAGO — Data on two immune checkpoint inhibitors for the treatment of urothelial cancer represent important findings for this type of cancer presented at the…
In the Journals

Indoor tanning rates drop in US adults between 2010 and 2013

July 1, 2015
Indoor tanning rates have dropped among adults in the United States between 2010 and 2013, according to recently published study results.Researchers analyzed National…
More News Headlines »
Tailored Therapies for Myelodysplastic Syndromes

Tailored Therapies for Myelodysplastic Syndromes

This activity is supported by an educational grant from Celgene Corporation.

Myelodysplastic syndromes (MDS) represent a group of myeloid clonal hemopathies with heterogeneous clinical…
More »
Meeting News Coverage Video
VIDEO: Complete lymph node dissection does not improve outcomes in SLNB-positive melanoma

VIDEO: Complete lymph node dissection does not improve outcomes in SLNB-positive melanoma

June 19, 2015
CHICAGO — Vernon K. Sondak, MD, chair of the department of cutaneous oncology at Moffitt Cancer Center and a…
More »
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
morganatic-roan
morganatic-roan